Transgenic animal models of EPO signaling |
Tg6 |
Overexpression of human EPO driven by PDGF-β promoter, males and females |
Trabecular bone loss, thin cortical bone, decreased marrow adiposity – femora |
Increased bone resorption and reduced bone formation rate |
Hiram-Bab et al., 2015; Suresh et al., 2019a
|
ΔEpoRE
|
Epor−/− mice rescued by erythroid restricted EPOR transgene (GATA-1 locus hematopoietic regulatory domain driving mouse EPOR cDNA), males and females |
Reduced trabecular bone, cortical bone unaffected, increased marrow adiposity – femora |
Increased bone resorption with age; reduced osteogenic potential of osteoblasts |
Suresh et al., 2019a |
Mice with EPOR deletion in osteoblasts |
Mice generated by crossing Osteocalcin (Bglap)-Cre mice with Eporfloxp/floxp mice, males and females |
Reduced trabecular bone, cortical bone, and marrow adiposity unaffected – femora |
No change in bone resorption; reduced osteogenic potential of osteoblasts; reduced osteocytes and increased empty lacunae |
Suresh et al., 2020b |
EPO administration in healthy animals |
Wild-type mice |
C57BL6 strain, female |
Trabecular bone loss – femora |
Increased bone resorption |
Hiram-Bab et al., 2015; Suresh et al., 2019a
|
Wild-type mice |
C57BL6 strain, male |
Trabecular bone loss – tibiae |
Increase in both bone resorption and bone formation |
Singbrant et al., 2011 |
Wild-type mice |
C57BL6 strain, gender unknown |
Increased bone mineral density and bone volume – vertebrae |
Increased osteoblasts on bone surface |
Shiozawa et al., 2010 |
ΔEpoRE
|
C57BL6 background, females |
No changes in trabecular or cortical bone – femora |
No changes in osteoblasts or osteoclasts |
Suresh et al., 2019a |
Mice with EPOR deletion in osteoblasts |
C57BL6 background, males and females |
Non-significant reduction in trabecular bone in males, intact trabecular bone in females, cortical bone unaffected in both males and females – femora |
No changes in osteoblasts or osteoclasts |
Suresh et al., 2020b |